Scarica l'app Stockscreener
2.22
3.06%
-0.07
Precedente Chiudi:
$2.29
Aprire:
$2.22
Volume 24 ore:
54,953
Relative Volume:
0.07
Capitalizzazione di mercato:
$5.03M
Reddito:
-
Utile/perdita netta:
$-12.88M
Rapporto P/E:
-0.9563
EPS:
-2.3215
Flusso di cassa netto:
$-10.85M
1 W Prestazione:
-6.72%
1M Prestazione:
-31.06%
6M Prestazione:
-61.05%
1 anno Prestazione:
-85.47%
Intervallo 1D:
$2.122
$2.3046
Intervallo di 1 settimana:
$2.122
$2.56
Portata 52W:
$2.05
$19.63
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Nome
Processa Pharmaceuticals Inc
Settore
Industria
Telefono
443-776-3133
Indirizzo
601 21ST STREET, SUITE 300, VERO BEACH
Compare PCSA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
2.22 | 5.19M | 0 | -12.88M | -10.85M | -2.3215 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-25 | Iniziato | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Borsa (PCSA) Ultime notizie
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Abilene Reporter-News
Will Processa Pharmaceuticals Inc. benefit from seasonality2025 Sector Review & Growth Focused Investment Plans - mfd.ru
Aug Technicals: Does Processa Pharmaceuticals Inc have a sustainable dividendJuly 2025 Volume & High Accuracy Investment Entry Signals - baoquankhu1.vn
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Erie Times-News
Does Processa Pharmaceuticals Inc. have a sustainable dividendQuarterly Earnings Report & Long-Term Safe Investment Plans - mfd.ru
Is Processa Pharmaceuticals Inc likely to announce a buybackGlobal Markets & Advanced Technical Analysis Signals - baoquankhu1.vn
Fed Meeting: Should I hold or sell Processa Pharmaceuticals Inc nowWeekly Market Summary & Free Community Supported Trade Ideas - baoquankhu1.vn
Jobs Data: What makes MNTK stock attractive todayJuly 2025 Sector Moves & Real-Time Market Trend Scan - baoquankhu1.vn
Why did Processa Pharmaceuticals stock surge 160% today? - MSN
Big Picture: Does Processa Pharmaceuticals Inc have a sustainable dividendInsider Buying & Accurate Buy Signal Alerts - baoquankhu1.vn
Pharma Sector Update: Amneal Valuation, Processa Profile, and Balaxi Earnings - scoopsquare24.com
Big Money Moves: Can Processa Pharmaceuticals Inc maintain sales growth2025 Analyst Calls & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Patterns Watch: Does Processa Pharmaceuticals Inc align with a passive investing strategy - baoquankhu1.vn
ETF Watch: Will Processa Pharmaceuticals Inc benefit from current market trendsQuarterly Trade Review & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Risk Hedge: Is Processa Pharmaceuticals Inc showing insider buyingRate Cut & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Processa Pharmaceuticals completes enrollment of 20th patient in Phase 2 study - MSN
Will Processa Pharmaceuticals Inc. benefit from current market trendsBull Run & AI Enhanced Execution Alerts - bollywoodhelpline.com
History Review: Should value investors consider Processa Pharmaceuticals IncJuly 2025 Closing Moves & Weekly Market Pulse Updates - baoquankhu1.vn
Stock Recap: Is Processa Pharmaceuticals Inc showing insider buying2025 Market WrapUp & Real-Time Market Sentiment Reports - baoquankhu1.vn
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference to Discuss NGC-Cap Phase 2 Study Results - Quiver Quantitative
Is Processa Pharmaceuticals Inc. stock supported by strong cash flowsMarket Risk Report & Fast Gain Swing Trade Alerts - ulpravda.ru
How Processa Pharmaceuticals Inc. stock reacts to oil pricesWeekly Gains Summary & Technical Buy Zone Confirmation - Улправда
User - FinancialContent
Will Processa Pharmaceuticals Inc. stock outperform value stocksLayoff News & Capital Efficiency Focused Strategies - Улправда
Biostar Pharmaceuticals (OTCMKTS:BSPM) versus Heatwurx (NASDAQ:PCSA) Critical Review - Defense World
Processa Pharmaceuticals Regains Nasdaq Minimum Bid Compliance - TipRanks
Processa Pharmaceuticals shares surge on encouraging cancer trial update - MSN
Processa Pharmaceuticals Inc Azioni (PCSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Processa Pharmaceuticals Inc Azioni (PCSA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lin Patrick | Chief Business - Strategy Off |
Jan 01 '26 |
Option Exercise |
0.00 |
193 |
0 |
1,753 |
| Guy Wendy | Chief Administrative Officer |
Jan 01 '26 |
Option Exercise |
0.00 |
193 |
0 |
1,256 |
| Bigora Sian | Chief Development Officer |
Jan 01 '26 |
Option Exercise |
0.00 |
249 |
0 |
1,604 |
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):